GLP-1
US$ 29.77
glp-1 drug cost Antagonists Increase Plan Spend - What's Next π¨ Important update on compounded
Description
doi: 10.1159/000494235
In a phase 2 clinical trial, CagriSema reduced HbA1c by 2.2% (p = 0.075) in comparison with semaglutide 2.4 mg alone [101]
"By Sept, I had lost 30kg but the costs that we incurred in five months were excessive
People least likely to quit using GLP-1 drugs are those using them to manage diabetes and those with higher incomes
2017;6:e00407
